Specialized Cancer Care Through Three Clinics
Cancer Neurology, Brain Metastases, Pituitary and Vision Change
Fellowship-trained neurologist and neuro-oncologist Sigmund Hsu, M.D., leads the Mischer Neuroscience Institute’s new Cancer Neurology Clinic for the treatment of patients with neurological issues resulting from chemotherapy, and the Brain Metastases Clinic, whose staff of affiliated neuro-oncologists, neuroradiologists, neuropathologists, oncologists and neurosurgeons works closely with oncologists to provide personalized and innovative care to patients with brain tumors.
“Our goal with both clinics is to provide a much-needed niche service to the general oncologic community,” says Dr. Hsu, who provides consultation at Memorial Hermann-Texas Medical Center, Memorial Hermann Memorial City Medical Center and Memorial Hermann The Woodlands Hospital. “Cancer patients present with a complex mix of health issues. The problem itself may be easy to identify but the cause can be more difficult to determine. Is the problem with a breast cancer patient’s leg related to a herniated disk – completely unrelated to the breast cancer – or is it related to radiation or chemotherapy toxicity or to the malignancy itself? As a neurologist I can look at the big picture from a comprehensive perspective.”
The two new clinics extend the range of services for brain tumor patients, an expansion begun in 2011 with the opening of MNI’s Pituitary and Vision Change Clinic, which brings together a diverse range of subspecialists to diagnose, evaluate and treat specific disorders.
Led by Arthur Day, M.D., vice chair, program director and director of clinical education in neurosurgery at MNI and a professor in the Vivian L. Smith Department of Neurosurgery at UTHealth Medical School, the clinic uses the same integrative approach that has brought national acclaim to MNI. Physicians at the clinic incorporate neurology,
endocrinology, neuro-ophthalmology, stereotactic radiosurgery with Gamma Knife® technology, diagnostic radiology, interventional neuroradiology, radiation oncology and neuropathology for a comprehensive diagnosis and treatment plan.
The team’s combined expertise includes pituitary-region tumors, including nonsecretory tumors, TSH-secreting tumors, growth hormone-secreting tumors (acromegaly), corticotrophin-secreting tumors (Cushing’s disease), prolactinsecreting tumors, craniopharyngiomas, Rathke’s cleft cysts and pituitary cysts. Parasellar tumors treated include meningiomas arising from the orbit or skull base near the pituitary gland and optic nerves, craniopharyngiomas, germ cell tumors, epidermoid cysts, gliomas and metastatic tumors.
Refer a patient to any of the three clinics or request a consult.